Expression of pro-inflammatory cytokines (IL-6 &amp; IL-18) exacerbate the risk of diabetic nephropathy in the Pakistani population

Maqsood, Maha; Sharif, Saima; Naz, Shagufta; Farasat, Tasnim; Manzoor, Farkhanda; Cheema, Maqsood; Saqib, Muhammad

doi:10.1007/s11033-023-08249-z

Cited by 6 publications

(1 citation statement)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…27 A recent study has reported the involvement of pro-inflammatory cytokines interleukin-16 and interleukin-18 gene expression with the development of diabetic nephropathy but it does not comment on the severity or early onset of disease. 28 There is no significant association found between these polymorphisms and the severity of early diabetic nephropathy except for a few genes in certain populations. Based on the discussion above it is evident that there was a need to explore polymorphism in more genes related to renal function like GLO-1, CBR-1, and ACE, and look for any association with the development of early severe diabetic nephropathy.…”

Section: Discussionmentioning

confidence: 96%

Determination of Glyoxalase-1 levels and Identification of Genetic Variants in GLO1 Gene in Patients of Diabetic Nephropathy

Shah,

Rashid,

Majeed

2024

Pak J Med Sci

View full text Add to dashboard Cite

Objective: To determine the association of diabetic nephropathy with glyoxalase-1 enzyme levels and a genetic missense variation (SNP rs4746) in its gene (GLO-1). Methods: This cross-sectional comparative study was conducted at the Department of Biochemistry and Molecular Biology, Army Medical College, Rawalpindi from November 2020 to December 2022. One hundred patients and one hundred and thirteen healthy controls were enrolled using the nonprobability convenience sampling method. Medical history and 10ml blood were obtained from each individual after written informed consent. Blood samples were subjected to biochemical tests and DNA extraction which was later used for single nucleotide polymorphism (SNP) analysis (C332C variant of rs4741 GLO-1 gene) using Tetra primer ARMS PCR and gel electrophoresis. Glyoxalase-1 enzyme activity in serum was measured using ELISA. Results: There was a significant difference in serum glyoxalase-1 levels in the two groups (p-value< 0.001). The patient group had lower levels (16.24 ± 22.51mg/dl) of glyoxalase-1 as compared to the control group (48.70 ± 42.54mg/dl). In genotypic analysis, 98 out of 100 control individuals had AA genotype-while only one had CC and another AC genotype. In the patient group, 94 out of 100 patients showed AA genotype, three AC, and three CC genotypes. As the statistical significance (p-value) was 0.37, there was no significant association found between AC or CC genotype and diabetic nephropathy. Conclusion: Glyoxalase-1 levels are linked to the development of diabetic nephropathy in our patients while a known missense variant rs4746 in the GLO-1 gene is not associated with increased risk. doi: https://doi.org/10.12669/pjms.40.4.8258 How to cite this: Shah SZH, Rashid A, Majeed A. Determination of Glyoxalase-1 levels and Identification of Genetic Variants in GLO1 Gene in Patients of Diabetic Nephropathy. Pak J Med Sci. 2024;40(4):652-656. doi: https://doi.org/10.12669/pjms.40.4.8258 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

show abstract

Section: Discussionmentioning

confidence: 96%